Correlation Between Statera Biopharma and Biotron

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Statera Biopharma and Biotron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Statera Biopharma and Biotron into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Statera Biopharma and Biotron Limited, you can compare the effects of market volatilities on Statera Biopharma and Biotron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Statera Biopharma with a short position of Biotron. Check out your portfolio center. Please also check ongoing floating volatility patterns of Statera Biopharma and Biotron.

Diversification Opportunities for Statera Biopharma and Biotron

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Statera and Biotron is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Statera Biopharma and Biotron Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotron Limited and Statera Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Statera Biopharma are associated (or correlated) with Biotron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotron Limited has no effect on the direction of Statera Biopharma i.e., Statera Biopharma and Biotron go up and down completely randomly.

Pair Corralation between Statera Biopharma and Biotron

Given the investment horizon of 90 days Statera Biopharma is expected to under-perform the Biotron. But the pink sheet apears to be less risky and, when comparing its historical volatility, Statera Biopharma is 2.9 times less risky than Biotron. The pink sheet trades about -0.16 of its potential returns per unit of risk. The Biotron Limited is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  2.06  in Biotron Limited on August 28, 2024 and sell it today you would lose (0.81) from holding Biotron Limited or give up 39.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.84%
ValuesDaily Returns

Statera Biopharma  vs.  Biotron Limited

 Performance 
       Timeline  
Statera Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Statera Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Statera Biopharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Biotron Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotron Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Statera Biopharma and Biotron Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Statera Biopharma and Biotron

The main advantage of trading using opposite Statera Biopharma and Biotron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Statera Biopharma position performs unexpectedly, Biotron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will offset losses from the drop in Biotron's long position.
The idea behind Statera Biopharma and Biotron Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Directory
Find actively traded commodities issued by global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm